Nuclera

United Kingdom
Cambridge, England, United Kingdom, CB24 9NP

Company profile

Nuclera company profile

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2013-08-27

Headquarters

Postal code
CB24 9NP
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
11
Total equity funding
$155.8M
Last funding
Series C / $12M / 2026-01-13
Last equity funding
Series C / $12M
Investors
18
Lead investors
5
Founders
3
Articles
98

Founders and investors

Founders

Gordon McInroyJiahao HuangMichael Chen

Lead investors

Elevage Medical TechnologiesInnovate UKJonathan MilnerRT PartnersVerve Ventures

Investors

Amadeus Capital PartnersBritish Business BankElevage Medical TechnologiesFuture Planet CapitalVerve Ventures